Implanet S.A. (ALIMP.PA)

EUR 0.11

(1.33%)

EBITDA Summary of Implanet S.A.

  • Implanet S.A.'s latest annual EBITDA in 2023 was -5.07 Million EUR , down -66.38% from previous year.
  • Implanet S.A.'s latest quarterly EBITDA in 2024 Q2 was -2.12 Million EUR , down 0.0% from previous quarter.
  • Implanet S.A. reported an annual EBITDA of -2.91 Million EUR in 2022, up 9.92% from previous year.
  • Implanet S.A. reported an annual EBITDA of -3.25 Million EUR in 2021, down -31.17% from previous year.
  • Implanet S.A. reported a quarterly EBITDA of -1.48 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Implanet S.A. reported a quarterly EBITDA of -3.17 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Implanet S.A. (2023 - 2012)

Historical Annual EBITDA of Implanet S.A. (2023 - 2012)

Year EBITDA EBITDA Growth
2023 -5.07 Million EUR -66.38%
2022 -2.91 Million EUR 9.92%
2021 -3.25 Million EUR -31.17%
2020 -2.46 Million EUR 21.23%
2019 -2.36 Million EUR 33.01%
2018 -4.43 Million EUR 6.78%
2017 -5.15 Million EUR 17.64%
2016 -5.82 Million EUR 9.15%
2015 -6.35 Million EUR -17.17%
2014 -5.71 Million EUR -34.02%
2013 -4.93 Million EUR -2.93%
2012 -2.82 Million EUR 0.0%

Peer EBITDA Comparison of Implanet S.A.

Name EBITDA EBITDA Difference
Affluent Medical SA -13.34 Million EUR 61.95%
Bluelinea Société Anonyme -323.98 EUR -1566972.041%
Carmat SA -50.45 Million EUR 89.937%
Diagnostic Medical Systems S.A. -7.05 Million EUR 28.057%
Euromedis Groupe -4.43 Million EUR -14.471%
Eurobio Scientific Société anonyme 18.98 Million EUR 126.741%
Ikonisys S.A. -2.34 Million EUR -116.27%
Median Technologies SA -19.58 Million EUR 74.077%
SpineGuard SA -3.49 Million EUR -45.189%
Theraclion SA -4.48 Million EUR -13.143%
Euroapi S.A. -155.39 Million EUR 96.733%
Guerbet SA 98.83 Million EUR 105.137%
Ion Beam Applications SA 12.53 Million EUR 140.519%
Koninklijke Philips N.V. 1.04 Billion EUR 100.488%
Sequana Medical NV -29.13 Million EUR 82.575%